Sam – Page 309 – biolegacy

Nexus Names Dr. Michelle K. Murray Chief Clinical Officer

Post author:Sam
Post published:September 26, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

Big Pharma Edgy After Revival of Gilead's Whistleblower Lawsuit

Post author:Sam
Post published:September 26, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-gilead2.jpg" NAME"Big Pharma Edgy After Revival of Gilead's Whistleblower Lawsuit" ALT"Big Pharma Edgy After Revival of Gilead's Whistleblower Lawsuit"September 27, 2017By Alex Keown, BioSpace.com Breaking News Staff<BR... Source: BioSpace

Providence Medical Technology Expands Offering Of Posterior Cervical Fusion Solutions

Post author:Sam
Post published:September 26, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

3 Biotechs Facing Big FDA Decisions in October

Post author:Sam
Post published:September 26, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-fda.jpg" NAME"3 Biotechs Facing Big FDA Decisions in October" ALT"3 Biotechs Facing Big FDA Decisions in October"September 27, 2017By Mark Terry, BioSpace.com Breaking News StaffCatalytic events in biopharma can...…

ADC Bio To Invest $11 Million On Bioconjugation Facility

Post author:Sam
Post published:September 26, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

MaxWell Biosciences CEO Faces Backlash After Openly Discriminating Against Men

Post author:Sam
Post published:September 26, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks3.jpg" NAME"MaxWell Biosciences CEO Faces Backlash After Openly Discriminating Against Men" ALT"MaxWell Biosciences CEO Faces Backlash After Openly Discriminating Against Men"September 27, 2017By Alex Keown, BioSpace... Source: BioSpace

Something in the Water at Dr. Reddy’s, FDA Says

Post author:Sam
Post published:September 26, 2017
Post category:Drug Industry Daily

Cloudy water got Indian drugmaker Dr. Reddy’s Laboratories in hot water with the FDA, a Form 483 inspection report shows. Source: Drug Industry Daily

Magellan Health Drugmaking Outlet Dinged by FDA

Post author:Sam
Post published:September 26, 2017
Post category:Drug Industry Daily

A New York City pharmacy that produces drugs as part of the multibillion-dollar Magellan Health healthcare management corporation was cited in an FDA warning letter for failure to maintain sterile…

Judge Dismisses Price-Fixing Claims Against Generic Drugmakers

Post author:Sam
Post published:September 26, 2017
Post category:Drug Industry Daily

A Pennsylvania federal judge dismissed a class-action lawsuit against more than 10 drugmakers that accused them of misrepresenting facts to inflate generic drug prices. Source: Drug Industry Daily

EMA’s Exodus From London Could Hit Staff Hard, Internal Survey Shows

Post author:Sam
Post published:September 26, 2017
Post category:Drug Industry Daily

The European Medicines Agency stands to lose nearly one-fifth of its staff when it leaves London, no matter which city in the European Union is selected for its new headquarters,…